Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7aa001f3235c07b0298867908d45e21 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2002-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c81c9bf661ebb88f4ba4b634992abaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e5254ddf60a0a8816b1a8717c03889f |
publicationDate |
2003-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2377172-A1 |
titleOfInvention |
Nfat transcriptional factors in tumor progression |
abstract |
The present invention provides methods for monitoring or determining the progression of a cancer or metastatic potential of a cancer. The invention also applies to determining the prognosis for a treatment of cancer. Further features of the invention are methods for identifying target genes involved in cancer which requires NFAT biological activity. |
priorityDate |
2002-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |